about
In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams.Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis.Loracarbef: a new orally administered carbacephem antibiotic.
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Loracarbef concentrations in middle ear fluid
@ast
Loracarbef concentrations in middle ear fluid
@en
type
label
Loracarbef concentrations in middle ear fluid
@ast
Loracarbef concentrations in middle ear fluid
@en
prefLabel
Loracarbef concentrations in middle ear fluid
@ast
Loracarbef concentrations in middle ear fluid
@en
P2093
P2860
P356
P1476
Loracarbef concentrations in middle ear fluid
@en
P2093
P2860
P304
P356
10.1128/AAC.34.10.2030
P407
P577
1990-10-01T00:00:00Z